News Release

Zogenix to Release Second Quarter 2015 Financial Results and Host Conference Call & Webcast on August 10


SAN DIEGO, Aug. 3, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders, today announced that it will report its financial results for the second quarter ended June 30, 2015 after the market close, and will host a corporate update conference call and webcast on Monday, August 10, 2015 at 4:30pm Eastern Time.

Monday, August 10, 2015 @ 4:30pm Eastern Time/1:30pm Pacific
Toll Free: 888-523-1228
International: 719-325-2177
Conference ID: 9869696
Replays, available through August 24, 2015
Toll Free: 877-870-5176
International: 858-384-5517
Conference ID: 9869696

About Zogenix

Zogenix, Inc. (ZGNX) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.

For more information, visit

CONTACT: Ann Rhoads
         Chief Financial Officer
         Zogenix, Inc.

         Andrew McDonald
         Founding Partner
         LifeSci Advisors, LLC
Zogenix, Inc.